The 2018 ASRM Research Blueprint

One of the main goals of the ASRM 2014 – 2019 Strategic Plan was to focus on research and called for the development of specific initiatives to enhance the activities and support for ASRM-sponsored Reproductive Research Programs.

ASRM's 75th Anniversary (1944-2019)

ASRM has commissioned the “American Society for Reproductive Medicine Legacy Exhibit,” a unique piece of three-dimensional commemorative art to mark the Society’s 75th Anniversary in 2019.

Guidance for Providers Caring for Women and Men Of Reproductive Age with Possible Zika Virus Exposure

In September 2016, the ASRM issued a Zika guidance for providers that addressed the care of non-pregnant patients desiring pregnancy. This document, now updated, is based on new information, including the recent MMWR Vol. 67, August 7, 2018 issued by the CDC, “Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Men with Possible Zika Virus Exposure – United States, August 2018.”e In particular, this revised ASRM document addresses those individuals and couples undergoing assisted reproductive technologies (ART) who are potentially imminently pregnant because of the high overall success rate of this infertility treatment, compared to other treatments and natural conception. These couples therefore should be considered to be in the periconceptional period and for them, this can be defined prospectively, whereas for those who conceive naturally, this period is defined retrospectively. Unlike patients attempting pregnancy on their own, achieving a pregnancy by an intervention such as ART is voluntary, and the active role of providers falls under the guiding principle of medicine of “do no harm.” This document was developed to specifically address couples who may be needing ART and/or the use of gametes and embryos.

Download a PDF of this document

NIH Announcement: Notice of Intent to Publish a Funding Opportunity Announcement for Reproductive Medicine Clinical Trials Program (R01 Clinical Trial Required)

In order to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), through the Fertility and Infertility Branch, has published a Notice of Intent (NOT-HD-18-012) to solicit applications for research consortia to conduct large-scale clinical trials to assess diagnostic and therapeutic interventions in infertility and reproductive medicine through a Request for Applications (RFA).   

Looking for Additional Information?
Visit our provider site at

Find a Health Care Provider